MAX PLANCK SOCIETY WARNS EUROPE LAGS BEHIND IN PHARMA RESEARCH
June 1st, 2009
BY KEITH NUTHALL
A SENIOR official from Germany's renowned Max Planck Institute has warned that Europe is "lagging behind" Japan and the United States regarding innovation, especially in the pharmaceutical sector. Ivan Baines, the institute's head of technology transfer warned a Brussels conference that tough European Union "gold standard" health regulations were deterring research into new medicines.
ENDS
A SENIOR official from Germany's renowned Max Planck Institute has warned that Europe is "lagging behind" Japan and the United States regarding innovation, especially in the pharmaceutical sector. Ivan Baines, the institute's head of technology transfer warned a Brussels conference that tough European Union "gold standard" health regulations were deterring research into new medicines.
ENDS
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.